CENP-F
(1999). doi:10.1074/jbc.274.26.18597. PMID 10373470.
“Farnesyl transferase inhibitors block the farnesylation of CENP-E and CENP-F and alter the association of CENP-E with the microtubules.”. J. Biol. Chem. 275 (39): 30451–7. (2000). doi:10.1074/jbc.M003469200. PMID 10852915.
“M phase-specific association of human topoisomerase IIIbeta with chromosomes.”. Biochem. Biophys. Res. Commun. 287 (1): 282–7. (2001). doi:10.1006/bbrc.2001.5580. PMID 11549288.
“Farnesylation of Cenp-F is required for G2/M progression and degradation after mitosis.”. J. Cell Sci. 115 (Pt 17): 3403–14. (2003). doi:10.1242/jcs.115.17.3403. PMID 12154071.
“Synergistic interaction of lovastatin and paclitaxel in human cancer cells.”. Mol.
”. J. Cell Biol. 143 (1): 49–63. (1998). doi:10.1083/jcb.143.1.49. PMC 2132809. PMID 9763420. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2132809/.
Zhu X (1999). “Structural requirements and dynamics of mitosin-kinetochore interaction in M phase.”. Mol. Cell. Biol. 19 (2): 1016–24. doi:10.1128/MCB.19.2.1016. PMC 116032. PMID 9891037. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC116032/.
“Immunohistochemical analysis of the proliferation associated nuclear antigen CENP-F in non-Hodgkin's lymphoma.”. Mod. Pathol. 12 (1): 69–74. (1999). PMID 9950165.
“The cloning and analysis of LEK1 identifies variations in the LEK/centromere protein F/mitosin gene family.”. J. Biol. Chem. 274 (26): 18597–604.